Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackfinch Spr. Regulatory News (BFSP)

Share Price Information for Blackfinch Spr. (BFSP)

Share Price is delayed by 15 minutes
Get Live Data
85.00    0.00 (0.00%)
Bid:
83.00
Ask:
87.00
Spread: 4.00 (4.819%)
Market Cap: £73.68m
BFSP Live PriceLast checked at - London Stock Exchange

Intraday Blackfinch Spr. Share Chart

Result of AGM

5 Jun 2025 18:12

RNS Number : 6970L
Blackfinch Spring VCT PLC
05 June 2025
 

Blackfinch Spring VCT plc (the "Company")

Results of Annual General Meeting (the "Meeting")

 

At the Annual General Meeting of the Company held on Thursday 5 June 2025 at 11.00am, the following resolutions were duly passed.

 

Ordinary Resolutions

 

1. To receive the Directors' Report and Financial Statements of the Company for the financial

year ended 31 December 2024 together with the Independent Auditor's Report thereon.

 

2. That the Directors' Remuneration Report for the year ended 31 December 2024 be approved other than

the part of such report containing the Directors' Remuneration Policy.

 

3. To appoint BDO LLP as auditor of the Company from the conclusion of the Meeting until the

conclusion of the next annual general meeting of the Company to be held in 2026 at which financial

statements are laid before the Company.

 

4. To authorise the Company's directors ("Directors") to fix the remuneration of the auditor.

 

5. To re-elect Peter Hewitt as a director of the Company.

 

6. To elect Nicholas Pillow as a director of the Company.

7. That, the Directors be and hereby are generally and unconditionally authorised in accordance with

Section 551 of the Companies Act 2006 (the "Act") to exercise all of the powers of the Company to allot

ordinary shares of 1 pence each in the capital of the Company ("Shares") or to grant rights to subscribe

for or to convert any security into Shares up to an aggregate nominal value of 500,000, representing

approximately 87% of the issued share capital of the Company as at 1 April 2025, being the latest

practical date prior to publication of this document, provided that the authority conferred by this

Resolution 7 shall expire at the conclusion of the Company's next annual general meeting or on the

expiry of fifteen months following the passing of this Resolution 7, whichever is the later (unless

previously renewed, varied or revoked by the Company in general meeting).

 

8. That, in accordance with article 34 of the Company's articles of association (the "Articles") and in

addition to existing authorities, the Directors be and are hereby generally and unconditionally authorised

in accordance with section 551 of the Act to exercise all the powers of the Company to allot and issue the

following Shares pursuant to the terms and conditions of the dividend reinvestment scheme adopted by

the Company on 6 June 2024 and in connection with any dividend declared or paid in the period

commencing on the date of this Resolution 8 and ending on the later of the date of the Company's next

annual general meeting or the date falling 15 months after the date of the passing of this Resolution 8

(unless previously renewed, varied or revoked by the Company in general meeting):

 

• Shares up to an aggregate nominal amount representing 10% of the issued share capital from time to time

(approximately 6m Shares at the date of this notice).

 

Special Resolutions

 

9. That, the Directors be and hereby are empowered pursuant to Section 570(1) of the Act to allot or make

offers or agreements to allot equity securities (which expression shall have the meaning ascribed to it in

Section 560(1) of the Act) for cash pursuant to the authority given in accordance with Section 551 of the

Act by Resolution 7 above as if Section 561(1) of the Act did not apply to such allotments, provided that

the power provided by this Resolution 9 shall expire at the conclusion of the Company's next annual

general meeting or on the expiry of fifteen months following the passing of this Resolution 9, whichever is

the later (unless previously renewed, varied or revoked by the Company in general meeting), save that the

Company may, prior to such expiry, make offers or agreements which would or might require equity

securities to be allotted after the expiry of the said power and the Directors may allot equity securities of

such offers or agreements notwithstanding the expiry of such power.

 

10. That, in accordance with section 570(1) of the Act, the Directors be and are hereby given power to allot

or make offers or agreements to allot equity securities (as defined in section 560 of the Act) for cash

pursuant to the authorities conferred by Resolution 8 above as if section 561 of the Act did not apply to

any such allotment, and so that:

 

10.1 reference to allotment of equity securities in this Resolution 10 shall be construed in accordance

with section 560 of the Act; and

 

10.2 The power conferred by this Resolution 10 shall expire at the conclusion of the Company's next

annual general meeting or on the expiry of fifteen months following the passing of this Resolution

10, whichever is the later (unless previously renewed, varied or revoked by the Company in

general meeting) save that the Company may prior to such expiry make offers or agreements

which would or might require equity securities to be allotted after the expiry of the said power and

the Directors may allot equity securities of such offers or agreements notwithstanding the expiry

of such power.

 

11. That, the Company be and is hereby authorised to make one or more market purchases (within the

meaning of section 693(4) of the Act) of Shares provided that:

 

11.1 the maximum aggregate number of Shares authorised to be purchased is an amount equal to

14.99% of the issued Shares as at the time of this notice (approximately 9m shares); 

 

11.2 the minimum price which may be paid for a Share is their nominal value;

 

11.3 the maximum price which may be paid for a Share is an amount equal to the

higher of (i) 105% of the average of the middle market quotation per Share taken from

the London Stock Exchange daily official list for the five Business Days immediately

preceding the day on which such Ordinary Share is to be purchased; and (ii) the amount

stipulated by the UK version of Article 5(6) of Market Abuse Regulation

(596/2014/EU); and

 

11.4 unless renewed, the authority hereby conferred shall expire either at the conclusion of

the annual general meeting of the Company following the passing of this Resolution 11

or on the expiry of fifteen months from the passing of this Resolution 11, whichever is

the later, save that the Company may, prior to such expiry, enter into a contract to

purchase Shares which will or may be completed or executed wholly or partly

after such expiry.

 

 

 

 

Resolution

For & Discretionary

Against

Withheld

1.

Directors' Report and Financial Statements and Auditor's Report

752,239

0

0

2.

Directors' Remuneration Report

708,232

6,912

37,095

3.

Appoint BDO LLP as auditor

731,689

6,912

13,638

4.

Auditor remuneration

747,339

0

4,900

5.

Re-elect Peter Hewitt

744,268

2,253

5,718

6.

Elect Nicholas Pillow

746,521

0

5,718

7.

Allot shares

738,601

0

13,638

8.

Allot shares pursuant to the DRIS

738,601

0

13,638

9.

Authority to disapply pre-emption rights

634,340

57,859

60,040

10.

Authority to disapply pre-emption rights re DRIS

634,340

57,859

60,040

11.

Share buyback authority

687,212

9,887

55,140

 

 For further information please contact:

 

Blackfinch Investments Limited (Investment Manager) - 01452 717070

 

The City Partnership (UK) Limited (Company Secretary) - enquiries@city.uk.com - Robin Smeaton

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSFFWIEISEFM
Date   Source Headline
26th Jun 20269:52 amRNSIssue of Equity
26th Jun 20269:46 amRNSTransaction in Own Shares
4th Jun 20263:51 pmRNSResults of AGM, 4 June 2026
21st May 20265:36 pmRNSDividend Declaration
18th May 20261:05 pmRNSIssue of Equity
7th May 20267:00 amRNSIssue of a Supplementary Prospectus
6th May 20269:46 amRNSTotal Voting Rights
28th Apr 20269:50 amRNSNet Asset Value per Share
21st Apr 20267:00 amRNSAnnual Financial Report
14th Apr 202612:59 pmRNSAdmission of Further Securities to Trading
31st Mar 20269:45 amRNSUtilisation of Over-allotment Facility
26th Mar 20261:48 pmRNSIssue of Equity
27th Feb 20267:00 amRNSIssue of Equity
2nd Feb 20265:17 pmRNSNet Asset Value per Ordinary Share
30th Jan 20264:59 pmRNSAdmission of Further Securities to Trading
28th Jan 20263:58 pmRNSIssue of Equity
27th Jan 20263:44 pmRNSChange of Registered Office Address
26th Jan 20262:23 pmRNSDeclaration of Interim Dividend
17th Dec 20256:26 pmRNSIssue of Equity
17th Dec 20256:22 pmRNSPurchase of Own Shares
20th Nov 20254:30 pmRNSIssue of Equity
19th Nov 20256:28 pmRNSIssue of Equity
10th Nov 20257:00 amRNSNet Asset Value per Share
19th Sep 20256:12 pmRNSPurchase of Own Shares
11th Sep 202511:49 amRNSPublication of Prospectus
26th Aug 20257:00 amRNSIssue of Equity
19th Aug 20254:26 pmRNSHalf-year Report
8th Aug 20255:01 pmRNSIssue of Equity
1st Aug 20259:07 amRNSNet Asset Value per Share
25th Jun 202512:37 pmRNSIssue of Equity
5th Jun 20256:12 pmRNSResult of AGM
2nd Jun 20253:55 pmRNSPurchase of own Securities
23rd May 202511:10 amRNSDeclaration of Interim Dividend
9th May 20254:25 pmRNSIssue of Equity
8th May 20251:39 pmRNSIssue of a Supplementary.Prospectus
6th May 20255:22 pmRNSNet Asset Value per Share
25th Apr 20256:28 pmRNSAnnual Financial Report
4th Apr 20253:06 pmRNSIssue of Equity
2nd Apr 20255:13 pmRNSIssue of Equity
31st Mar 202512:38 pmRNSUtilisation of Over-allotment Facility
26th Mar 20254:25 pmRNSIssue of Equity
27th Feb 20251:34 pmRNSIssue of Equity
11th Feb 20253:56 pmRNSNet Asset Value(s)
29th Jan 20255:52 pmRNSIssue of Equity
20th Jan 20255:21 pmRNSDividend Declaration
2nd Jan 20253:58 pmRNSTotal Voting Rights
13th Dec 20243:35 pmRNSIssue of Equity
4th Dec 20249:58 amRNSTotal Voting Rights
15th Nov 20245:11 pmRNSIssue of Equity
30th Oct 202411:59 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.